Efecto de la educación a través de Una aplicación móvil Con Reforzamiento médico y Nutricional Para Incidir en el Control metabólico, Conocimientos y Estilo de Vida de Los Pacientes Con Diabetes Tipo 2
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Female
- Sponsor
- Coordinación de Investigación en Salud, Mexico
- Enrollment
- 480
- Locations
- 1
- Primary Endpoint
- Number of participants with iipid profile in control targets
- Status
- Active, not recruiting
- Last Updated
- last year
Overview
Brief Summary
The objective of this study is to compare the effect of education through a mobile application with medical and nutritional reinforcement on the metabolic control of Mexican patients with type 2 diabetes attending primary care clinics in Mexico.
The research question is: What is the effect of education through a mobile application with medical and nutritional reinforcement vs.
nutritional and medical reinforcement, versus an educational platform to influence the metabolic control of patients with type 2 diabetes? Multicenter clinical trial in six family medicine units of the Mexican Institute of Social Security. These selected units are: UMF 9, UMF 28, UMF 7, UMF 1, UMF 9 and UMF 10.
Patients with type 2 diabetes will be randomly assigned to the educational intervention through the educational site, (n=160 patients), two clinics will be assigned for the use of the mobile App and the educational site (n=160 patients), and two clinics will be part of the control group (n=160 patients).
Detailed Description
Groups with educational website Participants will be invited to review the site at least once a week. There will be access to social networks and experts' blog for interaction with the patient, as well as an email for doubts with the researchers. The educational site has different educational modules that the patient can review dynamically, reinforcement messages and didactic activities at the end of each module to reinforce the learning acquired. The user will have free access to the educational platform. The educational site will automatically record the number of visits, modules and date of review and will be stored in a database. The above in order to measure adherence to the educational platform. Groups with educational site and App for reinforcement This group will have access to the App-DM2, which will be installed on the cell phones of patients with diabetes, will have a record for a family member who will serve as a support network for the review of the APP-DM2. It will be compatible with the Android platform. At the beginning of the study the researchers will register each patient and they will receive via SMS message and/or email. The software will be compatible with both Android Smartphone. The investigator will ask the patient to download the application for their initial visit and review it on subsequent visits. The control group will receive personalized counseling at the beginning of the study, both medical and nutritional, and will continue with their usual medical treatment provided in their family medicine units. All patients will be scheduled at 3, 6 and 12 months of follow-up for capillary glucose, blood pressure, anthropometry and body composition measurements as follow-up and monitoring measures. In all patients at baseline, 6 and 12 months, venous blood biochemical, clinical, anthropometric and dietary variables will be measured and used for statistical analysis.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Number of participants with iipid profile in control targets
Time Frame: The baseline and 12 months after the intervention will be evaluated.
Assessment of the effect of the intervention on lipid profile
Number of participants with body mass index profile in control target
Time Frame: The baseline and 12 months after the intervention will be evaluated.
Weight and height will be measured at baseline and at 12 months to obtain the body mass index.
Number of participants with glycosylated hemoglobin at control goals
Time Frame: 12 months
Glycosylated hemoglobin
Secondary Outcomes
- Number of patients with changes to a healthy lifestyle(The baseline and 12 months after the intervention will be evaluated.)
- The proportion of patients with adequate knowledge of diabetes(The baseline and 12 months after the intervention will be evaluated.)